107 related articles for article (PubMed ID: 1137127)
1. Simple elcetron capture gas chromatographic method for the determination of oral hypoglycemic biguanidis in biological fluids.
Matin SB; Karam JH; Forshan PH
Anal Chem; 1975 Mar; 47(3):545-8. PubMed ID: 1137127
[No Abstract] [Full Text] [Related]
2. Gas chromatographic determination of buformin in body fluids and tissues, using a nitrogen phosphorus detector: application to a postmortem case.
De Groot G; Maes RA; Sangster B; van Heijst AN; Verdonck LF
J Anal Toxicol; 1980; 4(6):281-5. PubMed ID: 7206658
[TBL] [Abstract][Full Text] [Related]
3. Determination of antihyperglycemic biguanides in serum and urine using an ion-pair solid-phase extraction technique followed by HPLC-UV on a pentafluorophenylpropyl column and on an octadecyl column.
Tahara K; Yonemoto A; Yoshiyama Y; Nakamura T; Aizawa M; Fujita Y; Nishikawa T
Biomed Chromatogr; 2006 Nov; 20(11):1200-5. PubMed ID: 16799926
[TBL] [Abstract][Full Text] [Related]
4. Liver uptake of biguanides in rats.
Sogame Y; Kitamura A; Yabuki M; Komuro S
Biomed Pharmacother; 2011 Sep; 65(6):451-5. PubMed ID: 21880461
[TBL] [Abstract][Full Text] [Related]
5. Application of ion-pair methods to drug extraction from biological fluids. II. Quantitative determination of biguanides in biological fluids and comparison of protein binding estimates.
Garrett ER; Tsau J; Hinderling PH
J Pharm Sci; 1972 Sep; 61(9):1411-8. PubMed ID: 5068947
[No Abstract] [Full Text] [Related]
6. RAdioimmunoassay of n-butylbiguanide.
Otting F
Methods Enzymol; 1982; 84():577-85. PubMed ID: 7098970
[No Abstract] [Full Text] [Related]
7. Fluorometric determination of biguanides in serum by high-performance liquid chromatography with reagent-containing mobile phase.
Kobayashi Y; Kubo H; Kinoshita T; Nishikawa T
J Chromatogr; 1988 Aug; 430(1):65-71. PubMed ID: 3215962
[TBL] [Abstract][Full Text] [Related]
8. Determination of metformin and other biguanides in forensic whole blood samples by hydrophilic interaction liquid chromatography-electrospray tandem mass spectrometry.
Sørensen LK
Biomed Chromatogr; 2012 Jan; 26(1):1-5. PubMed ID: 21374650
[TBL] [Abstract][Full Text] [Related]
9. A validated HPLC method with ultraviolet detection for the determination of buformin in plasma.
Chou CH; Cheng CL; Huang CC
Biomed Chromatogr; 2004 May; 18(4):254-8. PubMed ID: 15162388
[TBL] [Abstract][Full Text] [Related]
10. Gas chromatographic behavior of buformin hydrochloride, phenformin hydrochloride and phenylbiguanide. The pyrolytic formation of substituted 2,4,6-triamino-1,3,5-triazines from biguanides.
Wickramasinghe JA; Shaw SR
J Chromatogr; 1972 Sep; 71(2):265-73. PubMed ID: 5057114
[No Abstract] [Full Text] [Related]
11. Effects of metformin, buformin, and phenformin on the post-initiation stage of chemically induced mammary carcinogenesis in the rat.
Zhu Z; Jiang W; Thompson MD; Echeverria D; McGinley JN; Thompson HJ
Cancer Prev Res (Phila); 2015 Jun; 8(6):518-27. PubMed ID: 25804611
[TBL] [Abstract][Full Text] [Related]
12. Characterization of phenformin and metabolites in plasma.
Heuclin C; Pene F; Savouret JF; Assan R
Diabete Metab; 1975 Dec; 1(4):234-40. PubMed ID: 1234583
[TBL] [Abstract][Full Text] [Related]
13. [Comparison of the effects of phenformin, buformin and metformin on blood lactate level].
Czyzyk A; Lao B; Bartosiewicz W; Szczepanik Z; Orłowska K
Pol Arch Med Wewn; 1978 Mar; 59(3):241-54. PubMed ID: 673874
[No Abstract] [Full Text] [Related]
14. [Biguanides, rejection of treatment with buformin and fenformin, and restriction of indications for the use of metformin].
van Gestel WJ; Teijgeler CA
Ned Tijdschr Geneeskd; 1979 Jun; 123(22):948-9. PubMed ID: 450162
[No Abstract] [Full Text] [Related]
15. Solid phase extraction--non-aqueous capillary electrophoresis for determination of metformin, phenformin and glyburide in human plasma.
Lai EP; Feng SY
J Chromatogr B Analyt Technol Biomed Life Sci; 2006 Oct; 843(1):94-9. PubMed ID: 16787767
[TBL] [Abstract][Full Text] [Related]
16. [The risk of lacticate acidosis: a comparison of the 3 biguanides in treatment of diabetics (authors' transl)].
Irsigler K; Kritz H; Regal H; Foltin E
Wien Klin Wochenschr; 1978 May; 90(10):332-7. PubMed ID: 654296
[TBL] [Abstract][Full Text] [Related]
17. The enhancement of oxidative DNA damage by anti-diabetic metformin, buformin, and phenformin, via nitrogen-centered radicals.
Ohnishi S; Mizutani H; Kawanishi S
Free Radic Res; 2016 Aug; 50(8):929-37. PubMed ID: 27328723
[TBL] [Abstract][Full Text] [Related]
18. Buformin concentrations in a case of fatal lactic acidosis.
Verdonck LF; Sangster B; van Heijst AN; de Groot G; Maes RA
Diabetologia; 1981; 20(1):45-6. PubMed ID: 7202882
[TBL] [Abstract][Full Text] [Related]
19. [Biguanides in oral antidiabetic therapy: indications and limitations].
Gregorio F; Filipponi P
Medicina (Firenze); 1988; 8(3):262-8. PubMed ID: 3231038
[No Abstract] [Full Text] [Related]
20. [Semi-automatic determination of blood lactate during hypoglycemic treatment with biguanides].
Gelo Signorino R; Castellazzi R; Gamba S; Grassi G; Zanno C; Bruni B
Ann Osp Maria Vittoria Torino; 1979; 22(1-6):18-37. PubMed ID: 122229
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
